VistaGen Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 4.17 M | $14.75 M | 100.00% | 13.05% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 3.06 M | $10.86 M | 100.00% | 9.58% |
| TCG CROSSOVER MANAGEMENT, LLC | 11/17/2025 | 2.68 M | $9.50 M | 0.00% | 8.38% |
| STEMPOINT CAPITAL LP | 11/14/2025 | 2.49 M | $7.75 M | 3.13% | 7.79% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 1.98 M | $7.02 M | 0.00% | 6.20% |
| VANGUARD GROUP INC | 11/07/2025 | 1.69 M | $5.99 M | -4.09% | 5.29% |
| COMMODORE CAPITAL LP | 11/14/2025 | 1.58 M | $5.59 M | 0.00% | 4.93% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 620.87 K | $2.20 M | 3.19% | 1.94% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 550.00 K | $1.95 M | 100.00% | 1.72% |
| BLACKROCK, INC. | 11/12/2025 | 423.13 K | $1.50 M | 1.50% | 1.33% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 422.01 K | $1.50 M | 942.00% | 1.32% |
| DIADEMA PARTNERS LP | 11/14/2025 | 349.79 K | $1.24 M | -13.40% | 1.10% |
| JANE STREET GROUP, LLC | 11/14/2025 | 302.68 K | $1.07 M | 218.44% | 0.95% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 298.28 K | $1.06 M | 9.30% | 0.93% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 289.41 K | $1.03 M | 223.54% | 0.91% |
| JPMORGAN CHASE & CO | 11/26/2025 | 271.83 K | $964.98 K | -63.70% | 0.85% |
| ALMITAS CAPITAL LLC | 11/17/2025 | 261.40 K | $927.97 K | 0.00% | 0.82% |
| CITADEL ADVISORS LLC | 11/14/2025 | 242.60 K | $861.23 K | 261.55% | 0.76% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 231.30 K | $821.12 K | 100.00% | 0.72% |
| ADVISORSHARES INVESTMENTS LLC | 11/05/2025 | 207.00 K | $734.84 K | 1.91% | 0.65% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 197.02 K | $699.44 K | 10.78% | 0.62% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 157.03 K | $557.46 K | 507.90% | 0.49% |
| BML CAPITAL MANAGEMENT, LLC | 11/10/2025 | 150.00 K | $532.50 K | 0.00% | 0.47% |
| CITADEL ADVISORS LLC | 11/14/2025 | 122.06 K | $433.32 K | 100.00% | 0.38% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 113.06 K | $401.37 K | -73.13% | 0.35% |
| DIADEMA PARTNERS LP | 11/14/2025 | 100.20 K | $355.71 K | 50,000.00% | 0.31% |
| CITADEL ADVISORS LLC | 11/14/2025 | 99.50 K | $353.23 K | 177.16% | 0.31% |
| STATE STREET CORP | 11/14/2025 | 96.86 K | $343.85 K | 0.00% | 0.30% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 85.59 K | $303.86 K | -25.81% | 0.27% |
| PERSISTENT ASSET PARTNERS LTD | 11/10/2025 | 75.32 K | $267.38 K | -13.25% | 0.24% |
| XTX TOPCO LTD | 11/14/2025 | 69.71 K | $247.48 K | 100.00% | 0.22% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 68.02 K | $241.40 K | 56.86% | 0.21% |
| WALLEYE CAPITAL LLC | 11/14/2025 | 67.77 K | $240.58 K | 100.00% | 0.21% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 60.15 K | $213.54 K | 100.00% | 0.19% |
| NORTHERN TRUST CORP | 11/14/2025 | 48.09 K | $170.73 K | 0.00% | 0.15% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 45.20 K | $160.46 K | 100.00% | 0.14% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2025 | 43.95 K | $156.03 K | 100.00% | 0.14% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 11/14/2025 | 42.70 K | $151.60 K | 100.00% | 0.13% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 41.07 K | $145.81 K | 32.22% | 0.13% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 34.66 K | $123.03 K | 925.96% | 0.11% |
| GSA CAPITAL PARTNERS LLP | 11/07/2025 | 31.49 K | $112.00 K | 100.00% | 0.10% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 28.93 K | $102.69 K | 305.04% | 0.09% |
| MORGAN STANLEY | 11/14/2025 | 27.53 K | $97.75 K | 126.67% | 0.09% |
| UBS GROUP AG | 11/13/2025 | 25.67 K | $91.12 K | 12.51% | 0.08% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 23.30 K | $82.72 K | 0.00% | 0.07% |
| HIGHTOWER ADVISORS, LLC | 11/07/2025 | 20.83 K | $73.94 K | 0.00% | 0.07% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 20.68 K | $73.40 K | 100.00% | 0.06% |
| KESTRA ADVISORY SERVICES, LLC | 11/14/2025 | 20.03 K | $71.12 K | 0.00% | 0.06% |
| QUADRATURE CAPITAL LTD | 11/13/2025 | 15.75 K | $55.76 K | 100.00% | 0.05% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 14.50 K | $51.48 K | 100.00% | 0.05% |
VistaGen Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 73 institutional investors and hedge funds held shares of VistaGen Therapeutics, Inc.. The most heavily invested institutionals were:
JANUS HENDERSON GROUP PLC: 4.17 M
ORBIMED ADVISORS LLC: 3.06 M
TCG Crossover Management, LLC: 2.68 M
StemPoint Capital LP: 2.49 M
Nantahala Capital Management, LLC: 1.98 M
VANGUARD GROUP INC: 1.69 M
73.15% of VistaGen Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 24.17 M shares in the last 24 months. This purchase volume represents approximately $88.23 M in transactions.